Bio-Rad Laboratories, Inc. (BIO) vs Tempus AI, Inc. (TEM)
A side-by-side comparison of Bio-Rad Laboratories, Inc. and Tempus AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
BIO
Bio-Rad Laboratories, Inc.
$331.00HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
TEM
Tempus AI, Inc.
$42.90HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — BIO vs TEM
growth of $100 · dividends reinvested · last 2yBIO +11.6%TEM +6.6%BIO compounded faster
BIO TEM
BIO vs TEM: by the numbers
- •BIO is the larger company ($8.95B vs $7.51B market cap).
- •BIO is profitable (6.52% net margin) while TEM runs a net loss (-22.20%).
- •TEM grew revenue faster over the past five years (42.06% vs 0.29% CAGR).
Metrics side by side
Valuation
| Metric | BIO | TEM |
|---|---|---|
| P/E ratio | 52.13 | N/A |
| Forward P/E | 35.00 | N/A |
| P/S ratio | 3.29 | 5.63 |
| P/B ratio | 1.24 | 18.44 |
| EV / EBITDA | 21.48 | N/A |
| FCF yield | 4.19% | N/A |
Profitability
| Metric | BIO | TEM |
|---|---|---|
| Gross margin | 51.87% | 69.55% |
| Operating margin | 9.25% | -18.13% |
| Net margin | 6.52% | -22.20% |
| ROE | 2.46% | -72.74% |
| ROIC | 2.04% | -10.29% |
Growth (annualized)
| Metric | BIO | TEM |
|---|---|---|
| Revenue CAGR (5Y) | 0.29% | 42.06% |
| EPS CAGR (5Y) | -26.27% | N/A |
| FCF CAGR (5Y) | -7.57% | N/A |
| Total return CAGR (5Y) | -13.99% | N/A |
Frequently asked
- Which has grown faster, BIO or TEM?
- Over the past five years, TEM grew revenue faster — BIO at a 0.29% CAGR versus TEM at 42.06%.
- Is BIO or TEM more profitable?
- BIO runs the higher net margin — BIO at 6.52% versus TEM at -22.20%.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioTempus AI P/E ratioBio-Rad Laboratories dividend yieldTempus AI dividend yieldBio-Rad Laboratories ROETempus AI ROEBio-Rad Laboratories operating marginTempus AI operating marginBio-Rad Laboratories revenue growthTempus AI revenue growthBio-Rad Laboratories free cash flowTempus AI free cash flow
Bio-Rad Laboratories & Tempus AI appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.